VSTM (STOCKS)
Verastem, Inc.
$4.080000
-0.020000 (-0.49%)
Prev close: $4.100000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Daniel W. Paterson
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $351.49M
- Employees
- 78
- P/E (TTM)
- -1.50
- P/B (TTM)
- 4.40
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $49.59M |
| Benefits Costs and Expenses | $203.57M |
| Costs And Expenses | $220.44M |
| Operating Expenses | $220.44M |
| Selling, General, and Administrative Expenses | $88.42M |
| Research and Development | $123.67M |
| Other Operating Expenses | $8.35M |
| Operating Income/Loss | -$170.85M |
| Income/Loss From Continuing Operations After Tax | -$193.96M |
| Income/Loss From Continuing Operations Before Tax | -$136.16M |
| Interest Expense, Operating | $1.33M |
| Net Income/Loss | -$193.96M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$193.96M |
| Net Income/Loss Available To Common Stockholders, Basic | -$193.96M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.40 |
| Diluted Earnings Per Share | -$2.72 |
| Basic Average Shares | 242,340,000 |
| Diluted Average Shares | 251,090,000 |
| Assets | $227.81M |
| Current Assets | $202.90M |
| Cash | $181.70M |
| Inventory | $2.29M |
| Other Current Assets | $18.92M |
| Noncurrent Assets | $24.90M |
| Liabilities | $146.03M |
| Current Liabilities | $66.85M |
| Accounts Payable | $9.60M |
| Wages | $7.91M |
| Other Current Liabilities | $49.33M |
| Noncurrent Liabilities | $79.19M |
| Equity | $81.78M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $81.78M |
| Liabilities And Equity | $227.81M |
| Net Cash Flow From Operating Activities | -$150.95M |
| Net Cash Flow From Operating Activities, Continuing | -$150.95M |
| Net Cash Flow From Investing Activities | $3.11M |
| Net Cash Flow From Investing Activities, Continuing | $3.11M |
| Net Cash Flow From Financing Activities | $224.57M |
| Net Cash Flow From Financing Activities, Continuing | $224.57M |
| Net Cash Flow | $76.73M |
| Net Cash Flow, Continuing | $76.73M |
| Comprehensive Income/Loss | -$180.05M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$178.70M |
| Other Comprehensive Income/Loss | -$84.61M |